Merit Medical withdraws reimbursement application, pivots strategy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/5/2026

1. PTC
2. NVDA
3. PCVX
4. META
5. MSFT
6. SPY
7. GMAB
8. USO
9. GOOGL
10. AMD

Go back to Merit Medical withdraws reimbursement application, pivots strategy

Merit Medical Provides Update on U.S. Reimbursement and Commercial Strategies for WRAPSODY® Cell-Impermeable Endoprosthesis

November 13, 2025 4:05 PM EST

SOUTH JORDAN, Utah, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today that the U.S. Centers for Medicare & Medicaid Services (CMS) has notified Merit that its application for Transitional Pass-Through (TPT) incremental payment for WRAPSODY® Cell-Impermeable Endoprosthesis (CIE) procedures in the outpatient and ambulatory surgery center (ASC) settings requires further consideration prior to CMS making a final decision. CMS notified Merit that it has deferred Merits application for the WRAPSODY® CIE to the Calendar Year 2027 Outpatient Prospective Payment System rule, making January 1, 2027, the earliest possible effective... More